INFLUX

Influx Healthtech Share Price

₹158.45 +1 (0.64%)

20 Jul, 2025 20:59

SIP TrendupStart SIP in INFLUX

Start SIP

Performance

  • Low
  • ₹155
  • High
  • ₹160
  • 52 Week Low
  • ₹120
  • 52 Week High
  • ₹184
  • Open Price₹157
  • Previous Close₹157
  • Volume81,600

Investment Returns

  • Over 1 Month + 65.05%
  • Over 3 Month + 65.05%
  • Over 6 Month + 65.05%
  • Over 1 Year + 65.05%
SIP Lightning

Smart Investing Starts Here Start SIP with Influx Healthtech for Steady Growth!

Invest Now

Influx Healthtech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 367
  • P/B Ratio
  • 8.9
  • Average True Range
  • 11.25
  • EPS
  • 5.77
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 63.97
  • MFI
  • 72.9

Influx Healthtech Financials

Influx Healthtech Technicals

EMA & SMA

Current Price
₹158.45
+ 1 (0.64%)
pointer
  • stock-down_img
  • Bearish Moving Average 3
  • stock-up_img
  • Bullish Moving Average 2
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

157.75 Pivot Speed
  • R3 165.30
  • R2 162.55
  • R1 160.50
  • S1 155.70
  • S2 152.95
  • S3 150.90

What's your outlook on Influx Healthtech?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Influx manufactures nutraceuticals, cosmetics, herbal, veterinary, and homecare products across certified plants., offering contract manufacturing of tablets, capsules, gummies, powders, protein bars, and creams at competitive rates.

Influx Healthtech Ltd has an operating revenue of Rs. 340.08 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 17% is great, ROE of 36% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 5% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Group Rank of 82 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has some relative strength but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Influx Healthtech F&O

Influx Healthtech Shareholding Pattern

73.53%
0.07%
3.38%
0.25%
10.89%
11.88%

About Influx Healthtech

  • NSE Symbol
  • INFLUX
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Munir Abdul Ganee Chandniwala
  • ISIN
  • INE0MYZ01012

Similar Stocks to Influx Healthtech

Influx Healthtech FAQs

Influx Healthtech share price is ₹158 As on 20 July, 2025 | 20:45

The Market Cap of Influx Healthtech is ₹366.8 Cr As on 20 July, 2025 | 20:45

The P/E ratio of Influx Healthtech is 27.4 As on 20 July, 2025 | 20:45

The PB ratio of Influx Healthtech is 8.9 As on 20 July, 2025 | 20:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23